Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are-there-judges-and-lawyers-involved-Semantics-are-irrelevent
Implications are significant for the companies leadership.
This is not a traffic ticket... more like an accident with damages that might exceed any liability coverage available and as well possible incarceration of the defendants.
Company-likely-knows-FDA-status-ask-yourself-why-not-disclosing-publicly
The fact the FDA Clearance status is not known publicly is 99% probability because not good news considering the PR Speculation and subsequent TOXIC Dilution strategy in play with this company.
If there was even the slightest bit of good news concerning FDA there would be PR's and company facilitated dumping via TOXIC Dilution
SEC-Litigation-infers-TOXIC-dilution-proceeds-funneled-to-high-priced-defense-lawyers ;)
Little time for company leadership to focus on FDA activities
Not-feasible-for-LONG-term-LOOSING-shareholder-to-have-made-money-in-BIEL
LONG in BIEL is synonymous with investment financial LOSSES
SEC-and-FDA-have-provided-reliable-PREDICTION-of-what-to-expect
SEC --> Legal actions to cease and desist
FDA --> No Clearance to be provided
Greatest-Post-is-at-top-of-the-stickies-SEC-litigation-against-BIEL
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120375857
Dont-have-to-be-in-direct-contact-with-FDA-to-understand-the-reality
Reality is CEO basically stated FDA clearance would occur by year end 2015, there is a reason why the company is no longer making public comments on the status of FDA proceedings.
Just as the SEC has taken legal action to force cease and desist of unscrupulousness business activities and the process takes time for the mechanisms to be fully enforced, likewise FDA actions take time before publicly realized.
Whats-more-amusing-is-denial-of-the-reality-of-SEC-and-FDA-actions
Past Present and Future
Very-interesting-recommendation-and-subsequent-pps-movement
Not-according-to-the-SEC_and_FDA-who-you-gonna-trust-more-Andy-or-SEC_and_FDA
Very few rational investors would BIELeve there is not questionable activities....
SEC seems to think there is serious violations to the degree they have filed legal actions
to enforce "permanent cease and desist order" yet a 2nd time, 1st time for similar violations.
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
...REDACTED.... engaged in an illegal distribution of purportedly unrestricted
securities involving the sale of hundreds of millions of BIEL shares. Affiliates,
....REDACTED.... sold purportedly unrestricted shares in unregistered transactions
at a discount to then-current market prices. ....REDACTED.... President, CEO and the
principal financial officer of BIEL, and .....REDACTED...... orchestrated the illegal
distribution. Approximately half of the proceeds of these sales were then “loaned” to
BIEL and the other half was retained by the entities. The offerings were not registered
with the Commission. .....REDACTED..... failures to detect BIEL’s improper accounting,
as the auditor responsible for auditing the financial statements included in BIEL’s
Form 10-K, constitutes improper professional conduct.
What can you say about the FDA, but ddls is probably right, Company knows status and is blatantly not disclosing the FDA status.
Even-the-best-product-can-be/has-been-cannibalized-by-improper-business-practices
"Read-carefully"-now-thats-some-rational-unemotional-advice
Do not have to read very far, the allegations substantiate what has been suspected for many years.
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
...REDACTED.... engaged in an illegal distribution of purportedly unrestricted
securities involving the sale of hundreds of millions of BIEL shares. Affiliates,
....REDACTED.... sold purportedly unrestricted shares in unregistered transactions
at a discount to then-current market prices. ....REDACTED.... President, CEO and the
principal financial officer of BIEL, and .....REDACTED...... orchestrated the illegal
distribution. Approximately half of the proceeds of these sales were then “loaned” to
BIEL and the other half was retained by the entities. The offerings were not registered
with the Commission. .....REDACTED..... failures to detect BIEL’s improper accounting,
as the auditor responsible for auditing the financial statements included in BIEL’s
Form 10-K, constitutes improper professional conduct.
Major-RED-signals-provided-by-SEC-read-before-investing
Very few rational investors would BIELeve there is not questionable activities....
SEC seems to think there is serious violations to the degree they have filed legal actions
to enforce "permanent cease and desist order" yet a 2nd time, 1st time for similar violations.
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
...REDACTED.... engaged in an illegal distribution of purportedly unrestricted
securities involving the sale of hundreds of millions of BIEL shares. Affiliates,
....REDACTED.... sold purportedly unrestricted shares in unregistered transactions
at a discount to then-current market prices. ....REDACTED.... President, CEO and the
principal financial officer of BIEL, and .....REDACTED...... orchestrated the illegal
distribution. Approximately half of the proceeds of these sales were then “loaned” to
BIEL and the other half was retained by the entities. The offerings were not registered
with the Commission. .....REDACTED..... failures to detect BIEL’s improper accounting,
as the auditor responsible for auditing the financial statements included in BIEL’s
Form 10-K, constitutes improper professional conduct.
Reality-Check-what-legitimate-company-borrows-from-single-family-member-lender-companies
Very few rational investors would BIELeve there is not questionable activities....
SEC seems to think there is serious violations to the degree they have filed legal actions
to enforce "permanent cease and desist order" yet a 2nd time, 1st time for similar violations.
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
...REDACTED.... engaged in an illegal distribution of purportedly unrestricted
securities involving the sale of hundreds of millions of BIEL shares. Affiliates,
....REDACTED.... sold purportedly unrestricted shares in unregistered transactions
at a discount to then-current market prices. ....REDACTED.... President, CEO and the
principal financial officer of BIEL, and .....REDACTED...... orchestrated the illegal
distribution. Approximately half of the proceeds of these sales were then “loaned” to
BIEL and the other half was retained by the entities. The offerings were not registered
with the Commission. .....REDACTED..... failures to detect BIEL’s improper accounting,
as the auditor responsible for auditing the financial statements included in BIEL’s
Form 10-K, constitutes improper professional conduct.
Unreliable-information-halt-can-occurr-anytime-during-proceedings-without-advance-notice
Like most legal action, the authorities will not provide additional advance warning, the authorities do not provide you the exact date & time you will be evicted based on unlawful possession.
The public notice of proceedings is the best warning an investor will receive.
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
ROFLMAO-at-BS-speculator-investing-in-BIEL-TOXIC-Dilution-while--under-SEC-Investigation
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
All-TOXIC-Dilution-proceeds-likely-diverted-to-funding-legal-fees-for-SEC-investigation
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
All-company-efforts-focused-on-SEC-inquiry_and_response
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
Company-has-not-shared-any-sales-channel-metrics anything not directly from company is worse than pure speculation.
Total-BS-potentially-legal-implications-non-public-information-shared
SEC is aware of and interested as demonstrated in current legal filings: http://www.sec.gov/litigation/admin/2016/33-10036.pdf
RE:get-grilled-by-AW's-attorney You mean the Extremely expensive Attorney the unsuspecting investors have paid for via the toxic dilution scheme
No-evidence-from-company-statemnts-are-valid-PURE-SPECULATION-and-HYPE
Sure-did-produced-speculation-to-facilitate-buyers-for-toxic-dilution stock selling machine, which is the objective.
Positive-outcome-for-investor-very-low-probability
General opinions as follows:
o SEC would not proceed with filings/actions against penny-stock unless outcome very deterministic, if SEC had not taken action they could potentially be found to be negligent in meeting fundamental responsibilities to the public
o Past SEC actions filed against similar company individuals resulted in substantiating the requests to cease & desist
o Given multiple occurrences and failure to comply with underlying intent of previous cease & desist, current remediation/penalties will be far more severe than previous penalties
o Highest positive outcome for product innovation would be the company assets/IP will be forced sold to company like Boot's to take product line and benefit to public forward.
o Any benefit to investor will likely be similar to Bankruptcy proceedings
More-rational-interpretation-buyer-beware-high-risk High probability of total and complete loss of and monies invested
As outlined in SEC filing: http://www.sec.gov/litigation/admin/2016/33-10036.pdf
Glass-is-less-then-empty-has-been-for-years
Company operates on losses for many many years.
Only sustained tangible revenue stream is from toxic dilution strategy selling to investors hoping for a lottery ticket
SEC has documented illegal practices is its filings: http://www.sec.gov/litigation/admin/2016/33-10036.pdf
Yes-a-Ford-is-not-a-Chevy-however-TAM-is-shared
ActiPatch and SmartReleif are addressing same market space
Similar to the concept behind Advil, Bayer Asperin, Bufferin, Tylenol...
TAM --> Total Addressable Market
Consider-Smart-Relief-when-evaluating-BigPharma-conspiracy-theories
http://www.smartrelief.com
There are alternative OTC products available, suggest investigating revenues for this and similar products before contemplating theories that Big-Pharma is worried and working to limit Biel's products from wider availability.
Rational evaluation would deduce, Big-Pharma is not concerned and if they were they would have made the Biel family an "Offer they could not refuse"
Reality is this company appears to be 10-20% product based to establish 80-90% Stock selling channel. SEC has filed legal action and request the Biel family to respond to accusations with the intent of protecting further harm to investors.
Inquire with the company regarding how much funding has been derived from product sales versus how much from stock selling to unsuspecting investors? -->
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
http://www.prnewswire.com/news-releases/bioelectronics-corporation-refutes-sec-order-for-administrative-proceedings-300216474.html
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
Review the details of events that SEC feels represents multiple violations.
world-wide?
Whats the definition of world-wide....
Look close at the company web-site, referencing a distributor is not the same as product is being sold.
This is the type of PR vagueness that gets investors caught up in the speculative never met promises of something in the future.
SEC-Filings-suggest-all-data-derived-is-unreliable-at-best
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
This type of redundant repetitive speculative opinions are in part based on unreliable un-audited financials that the SEC has provided clear guidance to the contrary and taken legal action to correct.
The intent of the SEC filings are to protect the investors from harm that speculation like the opinions stated can induce.
world-wide-approved-according-to-what-data
Is there any data from the company showing number of products being sold in what regions/countries?
Whats the definition of "world wide approved" other then feel good comments & opinions.
yes there are PR's stating the product is "available" or "being sold by"....
What's lacking is reliable transparency of how many products are being sold where and at what price?
Given SEC filings financial reports from the company are suspect at best.
FDA-not-stonewalling-company-not-following-procedures
Ever worked with one of those slightly stubborn types that thinks they should be treated differently for what ever reason and is just not willing to follow process?
If FDA provides clearance and then it is subsequently determined the product has negative side affects and or simply does not meet advertised capabilities then assume the same individuals claiming FDA is "stonewalling" would be standing in line for some handout because FDA provided clearance for a product that did harm and or is ineffective.
FDA-has-not-aligned-with-that-opinion-and-thats-what-counts
Likely will not either given peer agency has concerns regarding fiduciary standards being practiced by the company leader and related family members and thus how can any data presented to FDA from this company be considered credible.
Boils-downto-SEC-has-provided-clear-concise-DD
See: http://www.sec.gov/litigation/admin/2016/33-10036.pdf
SEC has completed initial DD and acted upon those findings.
Subsequent action will be taken as those cited in the filing are given time to refute.
IMO This stock is a black-hole for any investor monies unless looking for a PR induced speculation bounce of 10-20%
Musical chair game, just try not getting caught holding the bag once SEC takes next "logical" steps.
Also-False-->"can he control the time frame"
RE: In no way shape or form can he control the time frame of a government agency.
Absolutely the company can influence the FDA, and has.... mostly negatively resulting in harm to investors,
If the company were to have followed procedures and not violated OTC laws in place intended to protect the public from devices that might do harm if not used in a proper manner.
Totally-False-CEO-->"No reason should not have clearance by year end"
RE: Since the law firm they hired to submit and handle their 510k took over the proceedings, we have heard "not a peep" of misinformation regarding anything positive or negative.
The CEO stated in a nationally aired "paid for" event: "no reason we should not have clearance before end of the year..."
For the record that was in 2015, thus there must be a reason the FDA has as of Feb-19-2016 NOT GRANTED clearance.
Maybe the FDA knew the company is under SEC investigations?
Not-about-feelings-about-violating-process-and-business-standards
The company violated FDA processes to the degree of bringing FDA's authority into question. As well skirting laws by re-branding as a solution for pet health care, which is a f-you in the face of the FDA from the company.
If the product was really valued by the consumer, they would just all go buy the product for their "Pets..." that was the ploy utilized by the company....
To convey "the little company being inhibited by the big bad FDA" is a joke, if this company used the investors monies in an appropriate manner the FDA process would have been followed and clearance provided years back.
Bottom line, this stock is a pure FDA speculation play, once/if cleared the bounce will not last long once it is discovered that the demand for the product is well below necessary levels.
This is exactly why the company does not release volume numbers, would hurt "Stock sales" speculative marketing campaigns and dissuade investors. IE: If they release too much details would cannibalize the stock selling scheme, which is the real money maker ;)
Company-needs-to-be-more-transparent-on-FDA-topics
The lack of transparency from company leads to more credibility in the SEC actions.
The information released from the company pertaining to FDA status is indicative of releasing just enough information to stimulate speculation, the lack of actionable progress suggests something wrong in either methods, process, strategy or likely all.
Basically company offended the integrity of the FDA authority and now is at the end of every possible queue that might exist.
It's not the FDA's fault that company leadership violated process and as result is now scrutinized to ensure the integrity of the process is not undermined.
Mess up at the DMV and go to the end of the longest line.
Lack-of-common-sense-and-logic
If one weighs SEC filings below PR's and years of unfulfilled FDA promises then not much can be said for the individuals common sense and or logic.
The reality is investing in this company is not logically supported by the facts, but the same can be said for the statistics of buying powerball lottery tickets when the chances of winning are less statistically probable then getting hit by lightning 3 times.
Investing without SEC pending action can be given some logical merits, but once the SEC begins sending out clear and concise warnings "Sell signals" to try and help unsuspecting investors then those left still chanting about the promises of a lottery ticket reward are no longer applying common sense or logic, they are simply playing the lottery with what is assumed to be expendable investment dollars.
If the SEC were to halt trading that would hurt those that "Logically" want to sell as result of the clear and concise warnings being provided. The SEC has not taken further action so as to benefit those investors applying logic and common sense, those left well will be "left holding the bag"
Now, that's not to say that "Traders" can not make money on bounces, the logically minded here can and do make money on the PR speculation scheme at play.
So, play the game "logically" and you can make money on this stock, just give strong weighting to the SEC warnings "shot across the bow" that this "game" play is based on the razor edge of criminal activity by those named in the filing(s).
Opinion-is-good-descriptor-for-PR
The PR's the company has been sending out more often then not really only amount to opinions to persuade unsuspecting investors.
Fundamentally stating the company is lacking tangible/actionable positive results that can drive the PPS.